EUVIMEDEUVIMED entdecken
Crossref

Czy istnieje związek między terapiami przeciwnowotworowymi a stężeniami witaminy C u pacjentów z rakiem prostaty?

Jakub Aleksander Bańkowski-Woźniak, Krzysztof Roszkowski

Postępy Żywienia Klinicznego · 2025

DOI: 10.5603/pzk.105775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Postępy Żywienia Klinicznego, 2025. Verfasst von Jakub Aleksander Bańkowski-Woźniak und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prostate cancer is the most commonly diagnosed malignancy among men in Poland. Radiotherapy is a key treatment modality that exerts cytotoxic effects primarily via oxidative stress. Vitamin C (VC) acts as a potent antioxidant and may influence cancer cell sensitivity to therapy. Previous studies suggest that steroid hormones and inflammatory mediators modulate VC transport into cells by regulating SVCT1/2 transporter expression. This study aimed to evaluate the impact of hormonal therapy and radiotherapy on VC concentrations in prostate cancer patients. Material and methods: A total of 45 patients undergoing either definitive or postoperative external beam radiotherapy were enrolled. Some patients concurrently received androgen deprivation therapy (GnRH analogues or antagonists). Plasma and peripheral blood leukocyte samples were collected before the initiation of radiotherapy and on the last day of treatment. Vitamin C levels were measured using ultra-performance liquid chromatography with tandem mass spectrometry (UPLC-MS) and ultra-performance liquid chromatography with ultraviolet (UPLC-UV). Statistical analyses were performed using Statistica 13.3, with p < 0.05 considered statistically significant.

Results

No statistically significant changes in plasma or intracellular VC concentrations were observed in patients undergoing hormonal therapy. In patients receiving radiotherapy without hormonal treatment, intracellular VC levels significantly decreased (p = 0.0015). In contrast, in patients receiving both radiotherapy and hormonal therapy, the decrease in intracellular VC was not statistically significant.

Conclusions

Radiotherapy is associated with a reduction in intracellular vitamin C levels, especially in patients not receiving hormonal therapy. Low testosterone levels may exert a protective effect, potentially by enhancing SVCT2 expression or reducing VC efflux. These findings suggest a hormone-dependent modulation of VC homeostasis and underscore the need for further research into VC transporter regulation in prostate cancer treatment.

Zitieren

APA

Bańkowski-Woźniak, J. A., & Roszkowski, K. (2025). Czy istnieje związek między terapiami przeciwnowotworowymi a stężeniami witaminy C u pacjentów z rakiem prostaty?. Postępy Żywienia Klinicznego. https://doi.org/10.5603/pzk.105775

Vancouver

Bańkowski-Woźniak JA, Roszkowski K. Czy istnieje związek między terapiami przeciwnowotworowymi a stężeniami witaminy C u pacjentów z rakiem prostaty?. Postępy Żywienia Klinicznego. 2025. doi:10.5603/pzk.105775

BibTeX
@article{BakowskiWoniak2025,
  author = {Bańkowski-Woźniak, Jakub Aleksander and Roszkowski, Krzysztof},
  title = {Czy istnieje związek między terapiami przeciwnowotworowymi a stężeniami witaminy C u pacjentów z rakiem prostaty?},
  journal = {Postępy Żywienia Klinicznego},
  year = {2025},
  doi = {10.5603/pzk.105775}
}
Kostenlos starten →